08045804946
medisus.pharma007@gmail.com
Change Language
ODENSOMAB 60MG INJ

ODENSOMAB 60MG INJ

8000.0 INR/Number

Product Details:

  • Packaging Type Prefilled Syringe
  • Dosage Form Injection
  • Life Span 2 years from date of manufacture
  • Indication Osteoporosis, cancer-induced bone loss, prevention of skeletal-related events
  • Salt Composition Denosumab
  • Pacakaging (Quantity Per Box) 1 prefilled syringe per box
  • Origin of Medicine India
  • Click to View more
X

ODENSOMAB 60MG INJ Price And Quantity

  • 1 Number
  • 8000.0 INR/Number
  • Approved by applicable drug regulatory authorities
  • Do not shake the syringe; inspect visually before administration
  • Not recommended
  • Musculoskeletal pain, hypercholesterolemia, hypocalcemia, rash, infections
  • Supplement with calcium and vitamin D; monitor calcium levels
  • 60 mg/ml
  • Clear, colorless to slightly yellow solution
  • Yes
  • Emcure Pharmaceuticals Ltd.
  • Subcutaneous
  • Anti-Osteoporotic Agent
  • Hypocalcemia, hypersensitivity to denosumab

ODENSOMAB 60MG INJ Product Specifications

  • India
  • ODENSOMAB
  • 1 prefilled syringe per box
  • Denosumab
  • Store in a refrigerator (2C to 8C). Do not freeze. Protect from light.
  • Osteoporosis, cancer-induced bone loss, prevention of skeletal-related events
  • Administered by healthcare professional; follow physicians instructions
  • Biological/Monoclonal Antibody
  • Injection
  • 2 years from date of manufacture
  • 60 mg single subcutaneous injection, every 6 months or as prescribed
  • Prevention of bone loss and fractures
  • Adults with osteoporosis and certain cancer-related bone conditions
  • Injection
  • Adults
  • Denosumab 60mg
  • Prefilled Syringe
  • 1 prefilled syringe
  • Approved by applicable drug regulatory authorities
  • Do not shake the syringe; inspect visually before administration
  • Not recommended
  • Musculoskeletal pain, hypercholesterolemia, hypocalcemia, rash, infections
  • Supplement with calcium and vitamin D; monitor calcium levels
  • 60 mg/ml
  • Clear, colorless to slightly yellow solution
  • Yes
  • Emcure Pharmaceuticals Ltd.
  • Subcutaneous
  • Anti-Osteoporotic Agent
  • Hypocalcemia, hypersensitivity to denosumab

ODENSOMAB 60MG INJ Trade Information

  • Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
  • 1000 Number Per Week
  • 2 Days
  • No
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

Odensomab (denosumab) belongs to a class of medicines called RANK ligand inhibitors. It functions by binding to a protein called the RANK ligand (RANKL), which is essential for the formation, function, and survival of osteoclasts (cells that break down bone tissue). By inhibiting RANKL, the medication reduces bone resorption (breakdown), thereby increasing bone mineral density and making bones stronger and less likely to fracture.
Key Uses
The 60 mg strength of Odensomab injection is used to manage several conditions:
  • Osteoporosis: Treatment of osteoporosis in postmenopausal women and men who are at high risk for fractures.
  • Bone Loss: To increase bone mass in patients with bone loss due to reduced hormone levels caused by certain cancer treatments (e.g., androgen deprivation therapy for prostate cancer or aromatase inhibitor therapy for breast cancer).
  • Giant Cell Tumor of the Bone (GCTB): To treat giant cell tumors of the bone by blocking specific receptors in the tumor cells, thus slowing their growth.
  • Hypercalcemia: To treat high calcium levels in the blood caused by cancer when other treatments have failed.


Comprehensive Bone Protection

ODENSOMAB 60MG INJ is specifically formulated to prevent bone loss and reduce the risk of fractures in adults suffering from osteoporosis or cancer-induced bone deterioration. As a monoclonal antibody, it targets bone resorption, offering substantial benefits to patients at risk of skeletal-related complications. Its efficacy and safety profile make it a trusted anti-osteoporotic solution.


Administration and Storage Guidelines

This medication is administered via subcutaneous injection, ideally by a healthcare professional. Each prefilled syringe contains a single 60 mg dose intended for use every six months, or as directed by your physician. ODENSOMAB should be stored in a refrigerator at 2C to 8C, never frozen, and protected from light. Prior to use, visually inspect the solution to ensure clarity and absence of particulates.


Patient Safety and Monitoring

It is crucial to ensure calcium and vitamin D supplementation while receiving ODENSOMAB. Regular monitoring of calcium levels is recommended to mitigate the risk of hypocalcemia. The treatment is not recommended during pregnancy and is contraindicated in patients with low calcium levels or known hypersensitivity to denosumab. Promptly report any adverse effects to your healthcare provider.

FAQ's of ODENSOMAB 60MG INJ:


Q: How is ODENSOMAB 60MG INJ administered?

A: ODENSOMAB 60MG INJ is given as a subcutaneous injection, usually in the upper arm, thigh, or abdomen, by a qualified healthcare professional. Each prefilled syringe delivers a 60 mg dose, typically administered every six months, based on your doctor's instructions.

Q: What conditions is ODENSOMAB recommended for?

A: ODENSOMAB is indicated for adults with osteoporosis and for the prevention of bone loss or skeletal-related events associated with certain cancers, such as those causing bone metastases.

Q: What precautions should I follow while using ODENSOMAB?

A: You should supplement with calcium and vitamin D as instructed by your doctor, and have your calcium levels monitored before and during treatment. ODENSOMAB is not recommended if you have hypocalcemia or known hypersensitivity to denosumab.

Q: What are the benefits of using ODENSOMAB 60MG INJ?

A: ODENSOMAB effectively reduces bone loss and lowers the risk of fractures in osteoporosis and cancer-induced bone conditions, helping maintain skeletal health and quality of life.

Q: What are the potential side effects of ODENSOMAB?

A: Common side effects include musculoskeletal pain, hypercholesterolemia, low calcium levels (hypocalcemia), skin rash, and increased risk of infections. Report any severe or persistent symptoms to your healthcare provider promptly.

Q: How should ODENSOMAB 60MG INJ be stored and handled?

A: Store the prefilled syringe in a refrigerator at 2C to 8C, away from light, and do not freeze. Do not shake the syringe, and always inspect the solution for clarity before use. The injection should only be administered by a healthcare professional.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top